AMBEV SA (BVMF: Abev3) has just published its annual results, and analysts update their estimates

It was a good week for Ambev SA (BVMF: Abev3) Shareholders because the company has just published its latest results of the year and the shares achieved 9.9% to $ 12.22. It was a subject -like result, with sales of 89 billion R $ in $ 2.3% before expectations and the statutory profit per share of $ 0.91 according to the analyst reviews. This is an important time for investors, since you can pursue the performance of a company in his report, see which experts are predicted for the next year and determine whether expectations change to the company. That is why we have collected the latest forecasts after the preservation to see which estimates are kept for next year.

Check out our latest analysis for Ambev

Taking into account the latest results, the consensus forecast from the 14 analysts from Ambev for sales of 93.6 billion R $ in 2025 refers to a reasonable improvement in sales compared to the last 12 months. The legal result per share is expected to increase by 8.0% to $ 0.99. Before this earnings report, the analysts in 2025 predicted sales of 93.2 billion R $ and the result per share (EPS) of 0.98 R $. The consensus analysts do not seem to have seen anything in these results because their estimates would have changed their view to the business.

The analysts confirmed their price target of $ 14.29 and showed that the company does well and meets expectations. The consensus price goal is only an average of the individual analyst goals. The most optimistic ambev analyst has a price target of $ 18.09 per share, while the most pessimistic estimates it at $ 11.05. Analysts definitely have different views of the business, but in our view the spread of estimates is not far enough to indicate that extreme results can wait for ambev shareholders.

Another way to look at these forecasts is of course to bring them into the context against the industry itself. We would emphasize that sales growth of AMBEV is expected to slower, with the forecast annual growth rate of 4.6% until the end of 2025 in the past five years far below the historical growth of 10% PA. Compare this with other companies (with analyst forecasts) in the industry, of which overall is expected to record sales of 6.0% annually. So it is quite clear that sales growth is expected, but that the wider industry will also grow faster than Ambev.

The end result

The most important thing you have to eliminate is that the mood has not changed significantly. The analysts now confirm that the business corresponds to its previous estimates of the profits per share. There were no significant changes in sales estimates on the positive side. Although forecasts imply that they do worse than the wider industry. The consensus goal was kept steadily at $ 14.29.

Against this background, we still believe that the long -term trajectory of the business for investors is much more important. At Simply Wall Street we have a wide range of analyst estimates for Ambev until 2027, and you can see them here for free.

Don't forget that there may still be risks. For example, we identified 1 warning sign for Ambev You should be aware of that.

Have feedback on this article? Worried about the content? Contact directly with us. Alternatively, email editorial team (at) simplywallst.com.

This article by Simply Wall Street is a general nature. We offer comments based on historical data and analyst forecasts that only use an impartial methodology, and our articles are not intended as financial advice. It is not a recommendation to buy or sell shares, and does not take into account your goals or your financial situation. We would like to use a long -term focused analysis by basic data. Note that our analysis may not take into account the latest record -sensitive announcements or qualitative material. Simply Wall Street has no position in the stocks mentioned.